NATO Innovation Fund leads $35 Million Series A in Portal Biotech alongside Earlybird to deliver world’s first full-length single-molecule protein sequencer

investmentsNIF News & InsightsJun 30, 2025

The NATO Innovation Fund and Earlybird led a $35 million Series A round in Portal Biotech, a pioneering biotechnology company headquartered in London. This represents one of Europe’s largest investments into a life sciences tools company and positions Porta...

Impact: LowConfidence: MediumNovelty: Material
investmentsnif-news-insights

See the whole story

Read the original on NIF News & Insights

Sens.ai aggregates and assesses published reporting. The assessment above is machine generated; the original source is authoritative.